Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.
The problems associated with the recognition and management of chronic hepatitis C in a population of individuals with confounding psychiatric disease are identified. The experience of treating such patients and the psychotropic medication required during treatment are reviewed.
Van Thiel
D H
DH
Department of Medicine, University of Kentucky School of Medicine, Lexington 40536, USA.
Friedlander
L
L
De Maria
N
N
Molloy
P J
PJ
Kania
R J
RJ
Colantoni
A
A
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000453:epidemiology*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D000998:Antiviral Agents; D011619:Psychotropic Drugs; D007372:Interferons